www.pharmatechoutlook.comED I T I O NNOVEMBER - 09 - 2023$15ISSN 2644-2787Ozgur Akbulut, Director, Global Divestments and Contract Manufacturing Lead, Takeda [NYSE:TAK] CDMOHOW CMOs/CDMOs CAN ADD VALUE FOR PHARMA COMPANIES
Page 2 >